Skip to main content

Table 1 Mean FTP radiation dose estimates for the control group (mSv/MBq, n = 10)

From: Validation of gallbladder absorbed radiation dose reduction simulation: human dosimetry of [18F]fluortriopride

Target organ

Mean

Standard deviation

Adrenals

1.48E−02

1.36E−03

Brain

4.77E−03

9.51E−04

Breasts

6.06E−03

7.53E−04

Gallbladder wall

4.36E−01

1.77E−01

Lower large intestine wall

3.38E−02

8.95E−03

Small intestine

8.68E−02

2.54E−02

Stomach wall

1.32E−02

1.19E−03

Upper large intestine wall

1.00E−01

2.91E−02

Heart wall

1.63E−02

2.85E−03

Kidneys

2.73E−02

3.47E−03

Liver

6.50E−02

1.05E−02

Lungs

2.70E−02

1.31E−02

Muscle

8.41E−03

3.01E−04

Ovaries

1.99E−02

3.88E−03

Pancreas

1.79E−02

2.32E−03

Red marrow

1.52E−02

7.40E−04

Osteogenic cells

1.28E−02

7.21E−04

Skin

5.15E−03

2.56E−04

Spleen

3.76E−02

3.47E−02

Testes

5.43E−03

2.80E−04

Thymus

6.81E−03

9.35E−04

Thyroid

5.32E−03

5.87E−04

Urinary bladder wall

1.91E−02

5.15E−03

Uterus

1.66E−02

2.74E−03

Total body

1.15E−02

5.50E−04

Effective dose equivalent

5.55E−02

1.12E−02

Effective dose

2.25E−02

2.20E−03